Aspen Pharmacare Holdings Limited
APNHF · OTC
6/30/2025 | 6/30/2024 | 6/30/2023 | 6/30/2022 | |
|---|---|---|---|---|
| Operating Activities | – | – | – | – |
| Net Income | $1,437,000 | $6,998,000 | $7,822,000 | $8,671,000 |
| Dep. & Amort. | $0 | $1,973,000 | $1,788,000 | $1,713,000 |
| Deferred Tax | $0 | $0 | -$435,000 | -$1,636,000 |
| Stock-Based Comp. | $0 | $117,000 | $135,000 | $58,000 |
| Change in WC | -$1,603,000 | -$242,000 | -$3,358,000 | -$2,652,000 |
| Other Non-Cash | $5,325,000 | -$2,621,000 | -$432,000 | -$780,000 |
| Operating Cash Flow | $5,159,000 | $6,225,000 | $5,520,000 | $5,374,000 |
| Investing Activities | – | – | – | – |
| PP&E Inv. | -$5,055,000 | -$3,117,000 | -$3,181,000 | -$2,697,000 |
| Net Acquisitions | -$229,000 | -$911,000 | $317,000 | $73,000 |
| Inv. Purchases | $0 | $0 | $0 | $2,697,000 |
| Inv. Sales/Matur. | $0 | $0 | $0 | $90,000 |
| Other Inv. Act. | $68,000 | -$5,440,000 | -$557,000 | -$2,324,000 |
| Investing Cash Flow | -$5,216,000 | -$9,468,000 | -$3,421,000 | -$2,161,000 |
| Financing Activities | – | – | – | – |
| Debt Repay. | $1,712,000 | $5,405,000 | $1,354,000 | -$1,623,000 |
| Stock Issued | $0 | $0 | $0 | $0 |
| Stock Repurch. | -$68,000 | -$56,000 | -$136,000 | -$1,857,000 |
| Dividends Paid | -$1,601,000 | -$1,525,000 | -$1,455,000 | -$1,196,000 |
| Other Fin. Act. | -$205,000 | -$201,000 | -$183,000 | $0 |
| Financing Cash Flow | -$162,000 | $3,623,000 | -$420,000 | -$4,676,000 |
| Forex Effect | -$592,000 | -$653,000 | $843,000 | $479,000 |
| Net Chg. in Cash | -$811,000 | -$273,000 | $2,522,000 | -$984,000 |
| Supplemental Information | – | – | – | – |
| Beg. Cash | $7,220,000 | $7,493,000 | $4,971,000 | $5,955,000 |
| End Cash | $6,409,000 | $7,220,000 | $7,493,000 | $4,971,000 |
| Free Cash Flow | $104,000 | $690,000 | $2,339,000 | $2,677,000 |